CA1135006A - Bone connective prostheses adapted to maximize strength and durability of prostheses-bone cement interface; and method of forming same - Google Patents

Bone connective prostheses adapted to maximize strength and durability of prostheses-bone cement interface; and method of forming same

Info

Publication number
CA1135006A
CA1135006A CA000345630A CA345630A CA1135006A CA 1135006 A CA1135006 A CA 1135006A CA 000345630 A CA000345630 A CA 000345630A CA 345630 A CA345630 A CA 345630A CA 1135006 A CA1135006 A CA 1135006A
Authority
CA
Canada
Prior art keywords
accordance
prosthesis
treatment
prosthetic element
bone
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA000345630A
Other languages
French (fr)
Inventor
Simon Raab
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/045,657 external-priority patent/US4281420A/en
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of CA1135006A publication Critical patent/CA1135006A/en
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/28Materials for coating prostheses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2/30767Special external or bone-contacting surface, e.g. coating for improving bone ingrowth
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2/32Joints for the hip
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2/32Joints for the hip
    • A61F2/36Femoral heads ; Femoral endoprostheses
    • A61F2/3601Femoral heads ; Femoral endoprostheses for replacing only the epiphyseal or metaphyseal parts of the femur, e.g. endoprosthetic femoral heads or necks directly fixed to the natural femur by internal fixation devices
    • A61F2/3603Femoral heads ; Femoral endoprostheses for replacing only the epiphyseal or metaphyseal parts of the femur, e.g. endoprosthetic femoral heads or necks directly fixed to the natural femur by internal fixation devices implanted without ablation of the whole natural femoral head
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/28Materials for coating prostheses
    • A61L27/34Macromolecular materials
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2/3094Designing or manufacturing processes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2/32Joints for the hip
    • A61F2/34Acetabular cups
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2/32Joints for the hip
    • A61F2/36Femoral heads ; Femoral endoprostheses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2/32Joints for the hip
    • A61F2/36Femoral heads ; Femoral endoprostheses
    • A61F2/3662Femoral shafts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2002/30001Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
    • A61F2002/30003Material related properties of the prosthesis or of a coating on the prosthesis
    • A61F2002/30004Material related properties of the prosthesis or of a coating on the prosthesis the prosthesis being made from materials having different values of a given property at different locations within the same prosthesis
    • A61F2002/30011Material related properties of the prosthesis or of a coating on the prosthesis the prosthesis being made from materials having different values of a given property at different locations within the same prosthesis differing in porosity
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2002/30001Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
    • A61F2002/30003Material related properties of the prosthesis or of a coating on the prosthesis
    • A61F2002/30004Material related properties of the prosthesis or of a coating on the prosthesis the prosthesis being made from materials having different values of a given property at different locations within the same prosthesis
    • A61F2002/30014Material related properties of the prosthesis or of a coating on the prosthesis the prosthesis being made from materials having different values of a given property at different locations within the same prosthesis differing in elasticity, stiffness or compressibility
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2/30767Special external or bone-contacting surface, e.g. coating for improving bone ingrowth
    • A61F2002/30906Special external or bone-contacting surface, e.g. coating for improving bone ingrowth shot- sand- or grit-blasted
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2/30767Special external or bone-contacting surface, e.g. coating for improving bone ingrowth
    • A61F2002/30925Special external or bone-contacting surface, e.g. coating for improving bone ingrowth etched
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2/30767Special external or bone-contacting surface, e.g. coating for improving bone ingrowth
    • A61F2002/30929Special external or bone-contacting surface, e.g. coating for improving bone ingrowth having at least two superposed coatings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2/32Joints for the hip
    • A61F2/36Femoral heads ; Femoral endoprostheses
    • A61F2/3609Femoral heads or necks; Connections of endoprosthetic heads or necks to endoprosthetic femoral shafts
    • A61F2002/3625Necks
    • A61F2002/3631Necks with an integral complete or partial peripheral collar or bearing shoulder at its base
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2/46Special tools or methods for implanting or extracting artificial joints, accessories, bone grafts or substitutes, or particular adaptations therefor
    • A61F2002/4631Special tools or methods for implanting or extracting artificial joints, accessories, bone grafts or substitutes, or particular adaptations therefor the prosthesis being specially adapted for being cemented
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2250/00Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2250/0014Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis
    • A61F2250/0018Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis differing in elasticity, stiffness or compressibility
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2250/00Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2250/0014Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis
    • A61F2250/0023Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis differing in porosity
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2310/00Prostheses classified in A61F2/28 or A61F2/30 - A61F2/44 being constructed from or coated with a particular material
    • A61F2310/00005The prosthesis being constructed from a particular material
    • A61F2310/00011Metals or alloys
    • A61F2310/00017Iron- or Fe-based alloys, e.g. stainless steel
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2310/00Prostheses classified in A61F2/28 or A61F2/30 - A61F2/44 being constructed from or coated with a particular material
    • A61F2310/00005The prosthesis being constructed from a particular material
    • A61F2310/00011Metals or alloys
    • A61F2310/00023Titanium or titanium-based alloys, e.g. Ti-Ni alloys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2310/00Prostheses classified in A61F2/28 or A61F2/30 - A61F2/44 being constructed from or coated with a particular material
    • A61F2310/00005The prosthesis being constructed from a particular material
    • A61F2310/00011Metals or alloys
    • A61F2310/00029Cobalt-based alloys, e.g. Co-Cr alloys or Vitallium
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2310/00Prostheses classified in A61F2/28 or A61F2/30 - A61F2/44 being constructed from or coated with a particular material
    • A61F2310/00389The prosthesis being coated or covered with a particular material
    • A61F2310/00952Coating, pre-coating or prosthesis-covering structure made of bone cement, e.g. pre-applied PMMA cement mantle

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Veterinary Medicine (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Cardiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Materials For Medical Uses (AREA)
  • Prostheses (AREA)

Abstract

ABSTRACT OF THE DISCLOSURE

There is disclosed a prosthesis comprising a prosthetic element and a polymethylmethacrylate film fixedly adhered thereto. The prosthesis comprises a surface adapted to be fixedly attached to bone and bears a polymethylmethacrylate film upon the attachment sur-face. The polymethylmethacrylate film is adhered to the prosthetic element by a process which comprises treating the prosthetic element surface to eliminate any weak boundary layer, applying polymethylmethacryl-ate to the treated surface, and thereafter annealing the polymethylmethacrylate film.

Description

il3SOO~;

BONE CONNECTIV~ PROST~ESES ADAPTED TO MAXIMIZE
STRENGTH AND DURABILITY OF PROSTHESES-BONE
CEMENT INTERFACE; AND METHODS OF FORMING SAME

Background of the Invention Field of the Invention The present invention relates to prostheses adapted to be fixedly attached to bone by means of a bone cement. Specifically, the present invention is directed towards prostheses adapted to maximize the strength and durability of the prostheses/bone cement adherence.

Description of the Prior Art A In the field of orthopedic surgery, ZIMALOY, a chromium-cobalt-molybdenum alloy, stainless ~teel~
titanium alloys~ and polymerized materials such as ultra high molecular weight polyethylene (hereinafter UHMWPE) have been used successfully to replace the ends of long bones and joints, including the hip joint.
However, there exists a severe limitation with respect to such orthopedic surgery, namely, coupling of the prostheses to bone. Due to such factors as mechanical stress, fatigue, corrosion, etc~, the prostheses/bone cement joints have been prone to failure.
Present methods of utilizing such bone pros-theses involve the use of a prosthesis having a stem portion which is inserted into the interior of a bone.

~ t~Jd? ,f,~, .k 500f~

A bone cement comprising a mixture of polymethylmeth-acrylate (hereinafter PMMA~ polymer and methyl meth-acrylate monomer and optionally including a styrene co polymer of PMMA is likewise inserted into the bone cavity and is utili ~ed to couple the stem of the implant to the the bone itself. Experience has demonstrated, however, that serious drawbacks exist with respect to the coupling between the prosthesis stem and the bone cement. At-tempted solutions to this problem have been directed primari ly toward strengthening the prosthesi s/bone cement interface by means of gross mechanical interlock involv-ing, for example, dove tails, small stems, etc. Such devices result in stress concentrations that can exceed the strength of the bone cement as well as cause non-physiological force distribution in the bone.
Adherence at the interface between the implant and PMMA is greatly restricted by current industrial and surgical practices~ For instance, the PMMA cement is typically applied in a highly viscous doughy state with the result that the degree of contact between the implant and the cement is inadequate. Moreover, the existence of weak boundary layers such as contaminants and weak metal oxides on the surface of the implant have also caused problems. Weak boundary layers may be due to the compo-sition of the implant or to the process of forming the same. Thus, in the case of a metal implant, the surface of the implant normally includes weak metal oxides as weak boundary layers. In the case of a polymeric im-plant, the surace of the implant normally includes a li;~500~;

weak boundary layer comprising monomer, partially poly-merized or low molecular weight polymer and contaminants comprising mold release agents, etc. Finally, the im-plant may come in contact with air, blood, water, etc.
prior to being inserted into the bone thereby becoming contaminated. The existence of weak boundary layers, e.g., surface contaminants, is detrimental to the for-mation of good implant-bone cement adherence. Thus, the strength of such joints has been dependent upon gross mechanical interlock. Such difficulties in the formation of a satisfactory prosthesis/ bone cement connection have also caused the result that mere resurfacing of a deter-iorated joint, e.g~, a deteriorated hip joint due to arthritis, was not readily accomplished~ Thus, in the case of a deteriorated articular surface, e.g., surface of the head or ball in a ball and socket joint, the en-tire head of the bone is generally removed and a pros-thetic head connected to the bone by means of a stem inserted into the interior of the bone, although in some instances, resurfacing implants have been used with bone cement.

Summary of the Invention It has now been discovered that prosthesis fixation problems may be overcome by treating at least that portion of the prosthesis which is adapted to be connected ~o bone in order to provide a PMMA film fixedly adhered to said portions of the prosthesis. Prior to the application of the PMMA film, the surface to be coated 0~;

is treated to eliminate any weak boundary layer existing thereon. Thereafter, a PMMA film is applied by dipping, painting spraying, etc., and finally, after the film has dried, it is annealed to remove any stresses in the film.
The resultant prosthesis has a film of P.~MA
firmly adhered to the surface thereof. This PMMA film adhesively interacts molecularly with PMMA bone cementO
Accordingly, the adherence of a prosthPsis adhesively connected to bone by means of a PMMA cement can be dras-tically increased.
In accordance with one aspect of this invention there is provided a prosthesis comprising a prosthetic element and a polymethylmethacrylate film fixedly adhered to at least a portion of the surface of said prosthetic element; said prosthesis comprising a surface adapted to be fixedly attached to bone by means of bone cement;
said prosthetic element bearing said polymethylmethacrylate film at least upon said attachment surface; said polymethyl-methacrylate film being adhered to said prosthetic elementby a process which comprises: treating said prosthetic element surface to elimina~e any weak boundary layer;
applying polymethylmethacrylate to said treated sur~ace;
and thereafter annealing said polymethylmethacrylate film.
In accordance with another aspect of this invention there is provided a process for fixedly adhering a polymethylmethacrylate fi:Lm to a prosthetic element to provide an improved prosthesis adapted ~o be joined to bone by means of bone cement which comprises:
treating said prosthetic element surface to eliminate any weak boundary layer;

50(~

applying polymethylmethacrylate to said treated surface;
and thereafter annealing said polymethylmetha-crylate film.
In accordance with another aspect of this invention there is provided a process comprising joining a prosthesis to bone by applying bone cement to a polymethylmethacrylate film fixedly adhered to a prosthetic element, said prosthesis having been prepared by the steps of:
treating said prosthetic element to eliminate any weak boundary layer;
applying polymethylmethacrylate to said treated surface to form a film thereon;
and thereafter annealing said polymethylmethacry-late film.
_ief Description of the Drawings In the drawings which form a part of the original disclosure of the present invention:
Fig. 1 is an elevational side view in longitudi-nal section of a PMMA coated hip prosthesis prepared in accordance with the present invention.
Fig. 2 illustrates an enlarged fragmentary view of a P~ ~ coated bone implantl as shown in Fig. 1, which has been fixedly adhered to the interior of a bone by m~ans of a PMMA bone cement.
Fig. 3 is a side elevational view of a human femur having a deteriorated head surface.
Fig. 4 is a perspective view of a prosthesis having a PMMA coating on the bone connective surface thereofO
The prosthesis may be utilized for resurfacing a deteriorated head surface of a ball and socket joint 4a -thus obviating the need for the removal of the head por-tion of the joint.
Fig. 5 illustrates an enlarged fragmentary cross-section of a deteriorated femur head bearing the resurfacing prosthesis of Fig. 4.

Detailed Description of the Invention ~

According to the present invention, prostheses exhibiting marked fixation improvements have been dis-covered. Such a prosthesis comprises a prosthetic element having a PMMA film fixedly adhered to at least a portion of the surface of the prosthetic element. The prosthesis includes a surface adapted to be fixedly attached to bone or a bone attachment surface. At least the bone attach-ment portion of the surface, in accordance with the present invention, is coated with a PMMA film prior to attachment to bone. The PMMA coating or film is adhered to the prosthetic element by a process which comprises treating the element surface to eliminate any weak bound-ary layer which may be present; applying PMMA to the treated surface; and annealing the PMMA film.
Fig. 1 is an elevational side view in longitud-inal section of a stem insertion hip joint prosthesis having a bone attachment surface bearing a PMMA film.
Also shown is a resurfacing prostheses for the socket portion of a hip joint, with the bone attachmènt surface having a PMMA film fixedly adhered thereto in accordance with the present invention. Thus, in Fig. 1 there is shown a stem insertion prosthesis 1, comprising a rigi~

li350()6 prosthetic element 2, which may be composed of a metal alloy or a polymer such as UHMWPE, bearing a thin, high strength PMMA film 3. Also shown is a resurfacing pros-thesis 4 for the socket portion of a ball and socket joint, comprising a rigid prosthetic element 5 and a PMMA film 6.
The rigid prosthetic element which is coated in accordance with the present invention may be chosen from any suitable material including metal alloys and plastic. Thus, the element may be composed of a titanium alloy, stainless steel, a cobalt-chromium or cobalt-chromium-molybdenum alloy, MP-35 (protozol~ or a poly-meric material such as ultrahigh molecular weight poly-ethylene (UHMWPE).
In order to provide a high strength PMMA film in accordance with the present invention, the prosthetic element must first be prepared. Preparation involves re-moval of any contaminants which may act as weak boundary layers so that the coating may be joined directly to the prosthetic element with no intervening materialO In the case of a metal prosthetic element, the weak boundary layer may comprise contaminants such as dirts and oils and additionally typically includes weak metal oxides.
In the case of a polymeric prosthetic element, thP weak boundary layer typically comprises contaminants such as unreacted monomer, anti-oxidation agents and mold release agents and additionally low molecular weight polymer.
In the case of a metal prosthetic element, re-moval of the weak boundary layer may involve a degreasing --~135006 step. Removal of the weak metal oxides is accomplishedby an acid treating step which may be followed by a de-smutting and passivation step. However, any treatment which functions effectively to remove contaminants and weak metal oxides may be utilized.
The degreasing treatment may be carried out through the utilization of an aqueous alkaline solution, such as, for example~ an aqueous solution of sodium hy-droxide. Thus, the prosthetic element to be degreased may be immersed in a 1 N solution of sodium hydroxide which has been heated to its boiling point, for 30 min-utes to remove contaminants and grease. Another degreas-ing treatment which may be utilized with less contam-inated elements comprises exposing the prosthetic ele-ment to trichloroethylene vapor. In order to determine whether or not degreasing is complete, the ~water break test" may be utilized according to which the degreased prosthetic element is rinsed in distilled water. When the element is removed from the water, if the water beads up and runs off in less than 30 seconds, the surface is not clean enough. There should be no break in the film of water nor any tendency of the film to crawl or pucker.
Subsequent to the degreasing treatment, the metallic prosthetic element should preferably be treated with an acid etching treatment in order to remove weakly bound metal oxides. Such treatment may comprise immers-ing the element in a sulfuric acid/water admixture at an elevated temperature of, for example, 60C. for a period of approximately 1/2 hour. Other treatments which may 1135~)06 be utilized include immersing the prosthetic element in a sulfuric acid/sodium dichromate aqueous solution or treatment with other acid solutions.
It is preferred that the acid etching treatment be discontinued prior to the accomplishment of any gross surface changes. Thus, it is preferred that the surface which is designed to be attached to bone~ be smooth.
This results in a more continuous stress concentration about the prosthetic element/bone cement interface. How-ever, where it is desired to use an implant having a rough surface thus promoting a greater degree of mechan-ical interlock, the coating of the present invention may be utilized and a stronger joint will result.
In the ca~e of an alloy prosthetic element which has ~een acid etched such as with the sulfuric acid solution discussed above, completion of the etching reaction will be evidenced by a reaction which turns the surface of the element black. This is due to the presence of carbon which is a component of metal alloys.
Such presence of carbon indicates that the surface has been sufficiently etched. If no carbon appears, etching is not complete. In order to avoid any gross surface changes, the element should be removed from the etching solution within ten seconds of the appearance of carbon.
The etched element may be checked by means of a Hobsyn Tally Surface Profile or an SEM to insure that no gross surface changes have occurred.
Thereafter, any carbon remaining on the surface of the element may be removed by means of a desmutting ~i3SOO~

and passivation treatment. Such desmutting and passiva-tion treatment may be carried out by means of a hydro-fluoric acid/nitric acid aqueous admixture heated to an elevated temperature of approximately 60~C. Other strong oxidation reagents may be utilized if desired.
When the etched element is immersed in such a solution, there should be a reaction within seconds evidenced by a burst of bubbles as carbon is removed. This is followed by another sudden burst of bubbles evidencing a secondary reaction. At this point, the element should be removed from the desmutting and passivation solution. This treatment functions not only to remove carbon but addi-tionally promotes the formation of a well adhered, uni-form, high strength oxide surface~ and is a preferred treatment stepr The initial removal of weak boundary layers may be carried out not only by chemical means, i.e., degreasing and acid etching, but mechanical means may be utilized if desired. Thus, the prosthetic element may be treated by blasting with alumina grit to provide a virgin metal surface. Other mechanical treatments such as grinding, honing, machining, etc., may also be uti-lized.
Following mechanical treatment of the pros-thetic element, the treated surface should immediately be immersed in a passivation solution comprising, e.g., nitric and hydrofluoric acid, as above. It is preferred that the passivation treatment be carried out within a short time from the mechanical treatment. The lapse 1~135~()6 of time between mechanical treatment and passivation should preferably be less than one minute.
Thereafter, the treated element should be rinsed in water until the water has a neutral pH. The ~reated element should thereafter be dried by any suit-able means such as by heating in an oven or by blowing the surface dry with a warm air stream.
Once the element has dried, it is allowed to cool to room temperature prior to application of the PMMA film thereto. Care must be taken that the clean surface not be contaminated during drying or cooling.
Coupling agents such as siloxane derivatives may be applied before the coating.
Thereafter, the PMMA film is applied to the prosthetic element. The film may be applied by means of painting, spraying, dipping, powder coating, electro-static coating, or in any other suitable manner in the form of a lacquer, powder or emulsion. The method and form utilized will depend on a number of various factors including the desired coating thickness, strength, im-plant geometry and surface roughness.
The film consists essentially of PMMA. How-ever, other materials may be included in the film such as cross-linking agents, free radical catalysts, acti-vators, plasticizers, chain transfer agents, inhibitors, plasticizing co-polymers 6 as well as adhesion promoters in the form of co-polymers, such as of acrylic acid and other freely orienting polar molecules.

11~50()6 One preferred method of applying the film to the prosthetic element comprises the application of a PMMA lacquer to the element. Application may take the form of dipping, spraying, etc. A PMMA lacquer is pre-pared by dissolving PMMA high molecular weight beads in a solvent such as dichloromethane. A small amount of barium sulfate may be added to the lacquer in order to keep the coated ~urface from crazing as well as making the coating radio opaque. The concentration of polymer in the solution should be in the range of 0.01 g. per ml. to about 0.8 9. per ml., preferably from about 0.2 g. per mlg to about 0.4 g. per ml., most preferably from about 0.25 g. per ml. to about 0.35 gO per ml.
The element is immersed in the lacquer for a period of time sufficient to form a suitable coating on the surface of the element. Such period of time may range from about 5 seconds to about 60 minutes, prefer-ably from about 15 minutes to about 60 minutes, most preferably from about 25 to 35 minutes.
Another method of applying the film to the proæthetic element comprises the application of PMMA
dissolved in methylmethacrylate (MMA), and additionally containing a conventional curing catalyst. Still another method of applying the PMMA coating is to coat the pros-thetic element with MMA and catalyst. In cases where MMA is used, a high temperature curing step follows the coating to polymerize the MMA to PMMA. This may consti-tute the annealing step discussed hereinafter.

Upon completion of the application of PMMA to the element, the PMMA film should be annealed by exposing the coated element to a temperature above that of the glass transition temperature of PMMA, i.e., 70-90~C, preferably 80Co The curing or annealing treatment is necessary to insure complete pvlymerization and removal of any volatile components from the film. High pressures~
i.e., greater than 100 psi may be applied to inhibit bubble formation. Moreover, by heating the film to a temperature above the glass transition temperature of PMMA, any mechanical stresses in the film developed during the drying thereof will be eliminated.
The rate at which the coated element is cooled following the annealing treatment is preferably carefully controlled to insure that it does not exceed about 1.5C.
per minute until the coated element reaches a temperature of about 80Co This insures that only minimal stresses are formecl in the film during cooling. If desired, the film may be crosslinked by chemical and/or radiation techniques.
The thickness of the film thus produced is not of critical importance; however, the preferred minimum thickness of the film should be about 0.0001 inch, more preferably about 0.001 inch, most preferably about 0.002 inch.
Upon completion of the annealing or ~uring of the PMMA film, the coated prosthetic element is ready for use as a prosthe~is. If the prosthesis is a bone implant prosthesis, the interior of the bone is removed so()~;

and cleaned and a PMMA bone cement is applied to the interior of the bone . Thereafter, the implant portion of the prostheses, coated in accordance with the present invention is inserted into the interior of the bone.
If desired, the coating may be softened with a solvent such as MMA monomer prior to insertion into the bone.
This causes the PMMA film to swell and so~ten, thus allowing for greater mechanical and chemical interaction between the coating and bone cement.
In Fig. 2, an enlarged fragmentary view of a coated prostheses which has been fixedly adhered to bone by means of a PMMA bone cement is illustrated. Pros-thetic element 2 is connected to bone cement 7 via the PMMA film 3. Bone 8 is shown to be adhered to the bone cement. The interface 9 between the PMMA film and the element is shown to be free of defects and any weak boundary layer due to the precoating treatment of the element. The interface between the PMMA coating and bone cement 10, represents both a chemical and mechanical adherence. Flaws 11 in the bone cement 7 may be dis-placed away from the interface 9 due to the interaction of the film and cement.
Where a prosthetic element comprising a poly-mer, especially UHM~E is to be utilized, a somewhat dif-ferent weak boundary layer removal treatment is utilized.
Such treatment comprises either an oxidation treatment or a treatment referred to by the acronym "casing" (cross-linking by activated species of inert gases)O The oxida-tion treatment may be performed by corona discharge, ~i3500~

flame treatment or an acid treatment, such as chromic acid, etc. The oxidation treatment accomplishes the re-moval of contaminants and low molecular weight polymers, i.e., polyethylene.
It is preferred that the polymeric element be degreased prior to the oxidation or casing treatment.
Such degreasing treatment is usually readily accomplished by immersing the polymeric element in trichloroethylene liquid for several seconds.
As previously mentioned, in lieu of surface oxidation treatment, the polymeric element may be treated by "casingn. This process consists of allowing electron-ically excited species of rare gasses to impinge upon the surface of the polymer~ As these metastable and ionic gasses come in contact with polyethylene, for ex-ample, they cause abstraction of hydrogen atoms and for-mation of polymer radicals at and near the surface of the polymer. The radicals formed by this process inter-act to form crosslinks and unsaturated groups without appreciable scission of the polymer chain. The mechan-ical strength of the surface region is increased remark-ably by the formation of a gel matrix. Thus, a weak boundary layer is transformed into a strong boundary layer. Wettability of the surface is relatively un-affected. Contact of the activated gas with the polymer surface for a time as short as one second will remarkably improve adhesive joint strength. Longer exposure times may be necessary when utilizing a more inert polymeric element such as, for instance, polytetrafluoroethylene.

11350()6 It is believed that substitution of casing for the oxida-tion treatment results in a more well adhered PMMA film.
Upon completion of the oxidation and/or casing treatment of the polymer surface, a P~MA coating is applied to the polymeric element in the same manner as previously discussed with respect to the metal element.
The PMMA film should thereafter be annealed or cured as with the coated alloy element. Annealing at a tem-perature of about 100C. is sufficient with a UHMWPE
element.
When a PMMA coating is applied to a prosthetic element in accordance with the present invention, the resulting prosthesis may be joined to bone cement and will exhibit markedly superior adherence to the same when compared to the adherence of bone cement to an uncoated prosthesis or when compared to the adherence of a coated prosthesis wherein the element pre-coating treatment and/or where the annealing treatment is not utilized.
The effect of the improved adherence between the prosthesis and bone cement results not only in im-proved adhesion of bone implant prosthesis to the in-terior of a bone but moreover may eliminate in some cases the need for using an implant stem. Thus, stems have been used in prosthetics to implant a steel object securely into the bone. However~ typically, the reason for the implant is a surface deterioration of the joint, for example, due to arthritis, but a mere resurfacing was not easily accomplished because of the fixation problems.

il350(~6 Recent advances in the application of cement to bone involves the pressurization of cement deep into the pores of bones creating intimate interlock. The only problem remaining has been the attachment of a metal surface to the cement wi~hout a stem. Such problem may be solved utilizing the P~MA coated prostheses of the present invention. Thus, i n Fig~ 3 there is shown a human femur 21 in elevational side view, with the head thereof having a deteriorated surface 22, due to, for example, arthritis. In the past, it would have been preferred to remove the entire head of the femur and to substitute a prosthetlc head connected to the femur by means of a stem insertionO However, by utilizing the present invention, an exterior surface may be fixedly attached to the deteriorated surface. The new prosthetic surface shown in Fig. 4 comprises a prosthetic element 23 which may be an alloy, and an inner surface 24 com-prising PMMA. It can be strongly adhered to the head of the femur when prepared according to the process of the present: invention, as shown in Fig. 5.
In Fig. 5 there is illustrated an enlargement of a fragmentary cross-section of a femur head after resurfacing. Bone cement 25 is shown extending deep into the surface of the bone 26. The bone cement is connected to the PMMA film 24; there being such forces as molecular bonding at the PMMA/PMMA-bone cement inter-face 27. The prosthetic element 23 i 5 thus connected by means of the PMMA film ar.d the bone cement to the resurfaced bone. Resurfacing prostheses of the present ~i;3S006 invention may be used not only for deteriorated ball and sock~t joints, but may be used in general on any deteriorated articular surface including, for example, a deteriorated knee.
The following examples serve to illustrate the formation of the prosthetic devices of the present invention and the improvement in results obtained by the use thereof.

Example 1 Preparation of a PMMA Lac~uer - Thirty grams of high molecular weight PMMA beads (manufactured by Fisher Chemical) are dissolved in 100 ml of dichloro-methane with stirring. When all of the beads have dis-solved, one gram of barium sulfate is added. The barium sulfate does not dissolve in the solution but rather, a portion becomes suspended in the solution rendering the solution opaque. The solution is allowed to stand for one-half hour in order to allow the barium sulfate to settle out. At the end of one-half hour the solution containing suspended barium sulfate is decanted from the barium sulfate sediment.
Pre aration of a Cobalt-Chromium Stem Insert P
Prosthetic Element - The surface of a dry grit blasted -cobalt-chromium alloy is to be coated. The element is first degreased by immersing it in 1 N solution of sodium hydroxide which has been heated to its boiling point.

The alloy element is allowed to remain in the alkaline ~35l)0~

bath for 30 minutes. Thereafter, the element is removed from the bath and rinsed with warm water until the water tests neutral.
The thus treated element is thereafter acid etched by means of a 50% by volume aqueous sulfuric acid solution. The element is immersed in the solution at a temperature of 60C. After about one-half hour a reac-tion which turns the surface black occurs. The element is removed from the acid solution and is rinsed in dis tilled water.
Following acid etching, the element is treated in a desmutting solution comprising an admixture of 15%
by volume of a 52~ hydrofluoric acid solution; 45% by volume nitric acid and 40% by volume water. The treated element is immersed in this solution at a temperature of from about 50 to about 60C. After ten seconds, there is a burst of bubbles indicating the removal of carbon.
This is followed by another sudden burst of bubbles indi-cating a secondary reaction. At this point the element is removed from the desmutting solution. Immediately upon removal the element is rinsed with distilled water until the water is neutral. The element is dried in an oven at a temperature of 110C. for approximately 5 to 10 minutes. The element is removed from the oven and allowed to cool to room temperaturer Applicatisn of the Coating The treated alloy element is immersed in the PMMA lacquer prepared earlier. After 30 minutes the ~ 18 -~3S~ 6 element is removed from the lacquer and placed into an oven at 60~C. The element is left in the oven for two hours.
Annealing Procedure The coated element is placed in an oven at 160C. for 18 hours. The element is removed from the oven and allowed to cool at a rate of 1 1/2C. per minute until the temperature is 70C. Thereafter, the element is cooled in open air. It is important that the coated element not be cooled too quickly due to the differences in rate of thermal contraction between the coating and the substrate.
The PMMA film produced thereby has a thickness of between 0.001 and 0.0015 inch.

Example 2 Preparation of a Polyethylene Element - A
UHMWPE prosthetic element is to be coated. The element is passed over a butane-oxygen flame until all parts of the surface have been exposed to the flame. Thereafter~
the treated element is exposed to activated species of an argon gas which have been generated by means of a high voltage discharge electrode in a vacuum chamber.
The treated polyethylene element is thereafter allowed to cool to room temperature and is then coated with the PMMA lacquer as described in Example 1. The coated poly ethylene element is dried in an oven at a temperature of 60C~ for two hours. Thereafter, the coating is an-nealed by heating the coated polyethylene element in .. .. .

~i350~6 an oven at 100C. for two hours. The substrate is slowly allowed to cool as described in Example 1.

Example 3 A stem insert sample is prepared and coated as described in Example 1. This sample and an uncoated stem insert sample are bonded to bone cement under a~bient conditions. The interface shear strength as measured by a cylindrical lap shear strength test for each element measured in mega Pascals and pounds/sq. in. is determined to be as follows:

Uncoated Pretreated, Coated and Annealed MPa (Standard Deviation) psi MPa
2.1 ~.5) 305 15.2 (.7) 22~0 The cylindrical lap shear strength test (re-ferred to above and in the following examples) is carried out as follows: A cylindrical sample to be tested is inserted into an annular mold containing PMMA/MMA bone cement and the cement is allowed to harden. The mold is removed to provide a cylindrical sample having an annular ring of bone cement bonded to a portion of the cylindrical surface. The sample is placed in a gripping device wherein it is gripped by means of the annular ring of bone cement. Force is applied axially to an end of the cylinder and the amount of force necessary to break the bond between the cylindrical sample and the annular ring of bone cement is recorded.

1~350~i Example 4 An alloy stem insert sample is prepared by de-greasing it, coating it with PMMA and annealing it, all as described in Example 1. For purposes of comparison, another prosthetic element is prepared in the same way, except that instead of annealing treatment, the PMMA
coating is cured at ambient temperature and is thereafter bonded to bone cement under ambient conditionsO The in-terface shear strengths as measured by a cylindrical lap shear strength test for the two elements are determined to be as follows:
Ambient CuredAnnealed MPa psi MPa psi
3-9 (~9) 4796.2 (.7) 900 Example 5 PMMA coa~ed stem insert samples are prepared as in Example 1. One is joined to bone cement under am-bient conditions while another is exposed to intermedul-lary contents, wiped with a saline solution and there-after joined to bone cement. The interface shear strengths of each are measured. There is no statisti-cally significant difference in values.
The above tests are performed on uncoated stem inserts. The interface shear strength of the uncoated, uncontaminated sample is significantly less than the coated sample and moreover, the interface shear strength of the contaminated sample shows a 50~ reduction in value with respect to the uncoated, uncontaminated sample.

- 2i -1~51306 Thus~ it can be seen that prostheses prepared in accordance with the present invention are unaffected by contamination while untreated prior art prostheses are greatly influenced by contamination.

Example 6 A UHMh~E sample is flame treated, coated with PMMA, dried and annealed as described in Example 2.
This sample and an unoated UHMWPE sample are bonded to bone cement under ambient conditions. The block shear strength for each sample is determined to be as follows:
Uncoated Coated MPa MPa psi Less than .1 5~1 (.5~ 740 The "block shear strengths" referred to above are measured as follows. A cubical or block sample having a flat surface to be tested which is treated or untreated as desired, is provided. A cube or block of bone cement is formed on the surface to be tested, by means of, e.g., a mold. After hardening of the bone cement the sample is gripped by the cube of bone cement. Force is applied to the sample and the amount of force required to break the cement bond between the sample and the cube of bone cement is recorded.

Claims (73)

WHAT IS CLAIMED IS:
1. A prosthesis comprising a prosthetic ele-ment and a polymethylmethacrylate film fixedly adhered to at least a portion of the surface of said prosthetic element;
said prosthesis comprising a surface adapted to be fixedly attached to bone by means of bone cement;
said prosthetic element bearing said poly-methylmethacrylate film at least upon said attachment surface;
said polymethylmethacrylate film being adhered to said prosthetic element by a process which comprises:
treating said prosthetic element surface to eliminate any weak boundary layer;
applying polymethylmethacrylate to said treated surface;
and thereafter annealing said polymethyl-methacrylate film.
2. A prosthesis in accordance with claim 1, wherein said prosthetic element is composed of metal.
3. A prosthesis in accordance with claim 2, wherein said treatment to eliminate said weak boundary layer comprises degreasing said metal prosthetic element with an alkaline reagent and thereafter treating said prosthetic element with an acidic reagent.
4. A prosthesis in accordance with claim 3, wherein said alkaline reagent comprises an aqueous solu-tion of an alkaline compound and said acidic reagent comprises an aqueous solution of an acidic compound.
5. A prosthesis in accordance with claim 4, wherein said degreasing treatment is carried out at a temperature of from about 200 to 220°F.
6. A prosthesis in accordance with claim 4, wherein said metal prosthetic element consists essen-tially of a cobalt-chromium-molybdenum alloy.
7. A prosthesis in accordance with claim 6, wherein said alkaline compound comprises sodium hydrox-ide.
8. A prosthesis in accordance with claim 7, wherein said acid treatment comprises an acid etching treatment followed by a desmutting and passivation treat-ment.
9. A prosthesis in accordance with claim 8, wherein said acid etching treatment comprises treating said prosthetic element with sulfuric acid and wherein desmutting and passivation treatment comprises treating said prosthetic element with an aqueous admixture of hydrofluoric acid and nitric acid.
10. A prosthesis in accordance with claim 3, wherein said prosthetic element is composed of stainless steel.
11. A prosthesis in accordance with claim 3, wherein said prosthetic element is composed of cobalt-chromium-molybdenum alloy.
1?. A prosthesis in accordance with claim 3, wherein said prosthetic element is composed of a titanium alloy.
13. A prosthesis in accordance with claim 1, wherein said prosthetic element is composed of ultra high molecular weight polyethylene.
14. A prosthesis in accordance with claim 13, wherein said treatment to eliminate said weak boundary layer comprises oxidizing said surface.
15. A prosthesis in accordance with claim 14, wherein said surface oxidation treatment comprises a treatment chosen from the group consisting of:
acid treatment, flame treatment or treat-ment by corona discharge.
16. A prosthesis in accordance with claim 1, wherein said application of said polymethylmethacrylate film to said treated surface comprises providing a solu-tion of polymethylmethacrylate and applying said solution to said treated surface.
17. A prosthesis in accordance with claim 16, wherein the solvent for said polymethylmethacrylate com-prises dichloromethane.
18. A prosthesis in accordance with claim 17, wherein said solution additionally comprises barium sul-fate.
19. A prosthesis in accordance with claim 16, wherein said annealing treatment comprises heating said prosthetic element bearing said film of polymethylmeth-acrylate to a temperature of greater than 80°Co.
20. A prosthesis in accordance with claim 1, wherein said annealing treatment comprises heating said prosthetic element bearing said polymethylmethacrylate film to a temperature of greater than 80°C.
21. A prosthesis in accordance with claim 20, wherein said prosthetic element is composed of metal.
22. A prosthesis in accordance with claim 20, wherein said prosthetic element is composed of ultra nigh molecular weight polyethylene.
23. A prosthesis in accordance with claim 1, comprising a bone implant prosthesis.
24. A prosthesis in accordance with claim 1 adapted to be fixedly attached to an articular surface of a bone.
25. A prosthesis in accordance with claim 24, wherein said articular surface of said bone comprises the ball portion of a ball and socket joint.
26. A prosthesis in accordance with claim 1, wherein said polymethylmethacrylate layer has a thickness greater than about 0.0001 inch.
27. A prosthesis in accordance with claim 1, wherein said treatment to eliminate any weak boundary layer comprises a mechanical treatment.
28. A prosthesis in accordance with claim 27, wherein said mechanical treatment comprises blasting with alumina grit.
29. In combination, a prosthesis as defined in claim 1 fixedly adhered to a bone by bone cement com-prising polymethylmethacrylate.
30. The combination of claim 29 wherein said prosthesis is a bone implant prosthesis.
31. The combination of claim 29 wherein said prosthesis is attached to an articular surface of said bone.
32. A process for fixedly adhering a poly-methylmethacrylate film to a prosthetic element to provide an improved prosthesis adapted to be joined to bone by means of bone cement which comprises:
treating said prosthetic element surface to eliminate any weak boundary layer;
applying polymethylmethacrylate to said treated surface;
and thereafter annealing said polymethylmetha-crylate film.
33. A process in accordance with claim 32, wherein said prosthetic element is composed of metal.
34. A process in accordance with claim 33, wherein said treatment to eliminate said weak boundary layer comprises degreasing said metal prosthetic element with an alkaline reagent and thereafter treating said prosthetic element with an acidic reagent.
35. A process in accordance with claim 34, wherein said alkaline reagent comprises an aqueous solu-tion of an alkaline compound and said acidic reagent comprises an aqueous solution of an acidic compound.
36. A process in accordance with claim 34, wherein said degreasing treatment is carried out at a temperature of from about 200 to 220°F.
37. A process in accordance with claim 35, wherein said metal prosthetic element consists essentially of a cobalt-chromium-molybdenum alloy.
38. A process in accordance with claim 35, wherein said alkaline compound comprises sodium hydrox-ide.
39. A process in accordance with claim 35, wherein said acid treatment comprises an acid etching treatment followed by a desmutting and passivation treatment.
40. A process in accordance with claim 39, wherein said acid etching treatment comprises treating said prosthetic element with sulfuric acid and wherein desmutting and passivation treatment comprises treating said prosthetic element with an aqueous admixture of hydrofluoric acid and nitric acid.
41. A process in accordance with claim 32, wherein said prosthetic element is composed of ultra high molecular weight polyethylene.
42. A process in accordance with claim 41, wherein said treatment to eliminate said weak boundary layer comprises oxidizing said surface.
43. A process in accordance with claim 42, wherein said surface oxidation treatment comprises a treatment chosen from the group consisting of:
acid treatment, flame treatment or treat-ment by corona discharge.
44. A process in accordance with claim 32, wherein said application of said polymethylmethacrylate film to said treated surface comprises providing a solu-tion of polymethylmethacrylate and applying said solution to said treated surface.
45. A process in accordance with claim 44, wherein the solvent for said polymethylmethacrylate com-prises dichloromethane.
46. A process in accordance with claim 44, wherein said annealing treatment comprises heating said prosthetic element bearing said film of polymethylmeth-acrylate to a temperature of greater than 80°C.
47. A process in accordance with claim 32, wherein said annealing treatment comprises heating said prosthetic element bearing said polymethylmethacrylate film to a temperature of greater than 80°C.
48. A process in accordance with claim 32, wherein said prosthesis is a bone implant prosthesis.
49. A process in accordance with claim 32, wherein said prosthesis is adapted to be fixedly attached to an articular surface of a bone.
50. A process in accordance with claim 32, wherein said polymethylmethacrylate layer has a thickness greater than about 0.0001 inch.
51. A process in accordance with claim 32, wherein said treatment to eliminate any weak boundary layer comprises a mechanical treatment.
52. A process in accordance with claim 51, wherein said mechanical treatment comprises blasting with alumina grit.
53. A process comprising joining a prosthesis to bone by applying bone cement to a polymethylmethacrylate film fixedly adhered to a prosthetic element, said prosthesis having been prepared by the steps of:
treating said prosthetic element to eliminate any weak boundary layer;
applying polymethylmethacrylate to said treated surface to form a film thereon;
and thereafter annealing said polymethylmethacry-late film.
54. A process in accordance with claim 53, wherein said prosthetic element is composed of metal.
55. A process in accordance with claim 54, wherein said treatment to eliminate said weak boundary layer comprises degreasing said metal prosthetic element with an alkaline reagent and thereafter treating said prosthetic element with an acidic reagent.
56. A process in accordance with claim 55, wherein said alkaline reagent comprises an aqueous solu-tion of an alkaline compound and said acidic reagent comprises an aqueous solution of an acidic compound.
57. A process in accordance with claim 56, wherein said degreasing treatment is carried out at a temperature of from about 200 to 220°F.
58. A process in accordance with claim 56, wherein said metal prosthetic element consists essentially of a cobalt-chromium-molybdenum alloy.
59. A process in accordance with claim 56, wherein said alkaline compound comprises sodium hydroxide.
60. A process in accordance with claim 56, wherein said acid treatment comprises an acid etching treatment followed by a desmutting and passivation treatment.
61. A process in accordance with claim 60, wherein said acid etching treatment comprises treating said prosthetic element with sulfuric acid and wherein desmutting and passivation treatment comprises treating said prosthetic element with an aqueous admixture of hydrofluoric acid and nitric acid.
62. A process in accordance with claim 53, wherein said prosthetic element is composed of ultra high molecular weight polyethylene.
63. A process in accordance with claim 62, wherein said treatment to eliminate said weak boundary layer comprises oxidizing said surface.
64. A process in accordance with claim 63, wherein said surface oxidation treatment comprises a treatment chosen from the group consisting of:
acid treatment, flame treatment or treat-ment by corona discharge.
65. A process in accordance with claim 53, wherein said application of said polymethylmethacrylate film to said treated surface comprises providing a solution of polymethylmethacrylate and applying said solution to said treated surface.
66. A process in accordance with claim 65, wherein the solvent for said polymethylmethacrylate comprises dichloromethane.
67. A process in accordance with claim 65, wherein said annealing treatment comprises heating said prosthetic element bearing said film of polymethylmeth-acrylate to a temperature of greater than 80°C.
68. A process in accordance with claim 53, wherein said annealing treatment comprises heating said prosthetic element bearing said polymethylmethacrylate film to a temperature of greater than 80°C.
69. A process in accordance with claim 53, wherein said prosthesis is a bone implant prosthesis.
70. A process in accordance with claim 53, wherein said prosthesis is adapted to be fixedly attached to an articular surface of a bone.
71. A process in accordance with claim 53, wherein said polymethylmethacrylate layer has a thickness greater than about 0.0001 inch.
72. A process in accordance with claim 53, wherein said treatment to eliminate any weak boundary layer comprises a mechanical treatment.
73. A process in accordance with claim 72, wherein said mechanical treatment comprises blasting with alumina grit.
CA000345630A 1979-02-15 1980-02-14 Bone connective prostheses adapted to maximize strength and durability of prostheses-bone cement interface; and method of forming same Expired CA1135006A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB79/05445 1979-02-15
GB7905445 1979-02-15
US45,657 1979-06-05
US06/045,657 US4281420A (en) 1979-02-15 1979-06-05 Bone connective prostheses adapted to maximize strength and durability of prostheses-bone cement interface; and methods of forming same

Publications (1)

Publication Number Publication Date
CA1135006A true CA1135006A (en) 1982-11-09

Family

ID=26270588

Family Applications (1)

Application Number Title Priority Date Filing Date
CA000345630A Expired CA1135006A (en) 1979-02-15 1980-02-14 Bone connective prostheses adapted to maximize strength and durability of prostheses-bone cement interface; and method of forming same

Country Status (5)

Country Link
AU (1) AU527190B2 (en)
CA (1) CA1135006A (en)
DE (1) DE3005264A1 (en)
FR (1) FR2448890B1 (en)
GB (1) GB2044129B (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2509986B1 (en) * 1981-07-23 1985-10-25 Benoist Girard Cie Sa IMPLANTS AND PROSTHESES IN PLASTIC MATERIAL, REINFORCED BY AN INSERT, FOR ORTHOPEDIC AND TRAUMATOLOGICAL SURGERY AND METHOD OF MANUFACTURE
GB2116848B (en) * 1982-03-19 1984-11-28 James Michael Sheehan Element for prosthetic joint
KR890003069B1 (en) * 1985-06-10 1989-08-21 구레하 가가꾸 고오교오 가부시끼가이샤 Implant material
US5184657A (en) * 1990-11-26 1993-02-09 Hatchman Robert M Multi-compartmented wallet and method of construction
EP0681845B1 (en) * 1994-04-11 1999-09-22 Bristol-Myers Squibb Company Polymer composite implant and method of making the same
DE19501771A1 (en) * 1995-01-21 1996-07-25 Aldinger Guenther Artificial joint, especially a hip joint endoprosthesis
DE19605735C2 (en) * 1995-12-01 2002-01-10 Dietmar A Kumm Periprosthetic retention systems
DE19612648C2 (en) * 1996-03-29 2001-12-06 Dietmar A Kumm Bracket systems for acetabular endoprostheses
DE19613200C2 (en) * 1996-04-02 2001-12-20 Dietmar A Kumm Periprosthetic mounting systems for femoral head endoprostheses

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3609867A (en) * 1969-03-10 1971-10-05 Research Corp Plastic bone composition
US3649345A (en) * 1969-04-01 1972-03-14 Roberto Tolosa Method of coating dentures to provide a polished surface
US3789029A (en) * 1970-07-06 1974-01-29 Research Corp Plastic bone composition and method of making same
US3907609A (en) * 1974-02-14 1975-09-23 Mc Donnell Douglas Corp Conversion coating for titanium and titanium base alloys
US3986212A (en) * 1975-04-11 1976-10-19 Glasrock Products, Inc. Composite prosthetic device with porous polymeric coating

Also Published As

Publication number Publication date
GB2044129B (en) 1983-01-26
GB2044129A (en) 1980-10-15
FR2448890B1 (en) 1985-09-20
FR2448890A1 (en) 1980-09-12
DE3005264C2 (en) 1989-10-05
AU5554280A (en) 1980-08-21
DE3005264A1 (en) 1980-08-28
AU527190B2 (en) 1983-02-17

Similar Documents

Publication Publication Date Title
US4281420A (en) Bone connective prostheses adapted to maximize strength and durability of prostheses-bone cement interface; and methods of forming same
US4365359A (en) PMMA Coated bone connective prostheses and method of forming same
US6984236B2 (en) Bone connective prosthesis and method of forming same
US6136038A (en) Bone connective prosthesis and method of forming same
AU672883B2 (en) Cleaning porous and roughened surfaces on medical implants
US7501073B2 (en) Methods for producing metallic implants having roughened surfaces
EP1449544B1 (en) Metallic implants having roughened surfaces and methods for producing the same
Ahmed et al. Metal/cement interface strength in cemented stem fixation
Raab et al. Thin film PMMA precoating for improved implant bone–cement fixation
JP3380563B2 (en) Orthopedic implant and its construction method
CA1135006A (en) Bone connective prostheses adapted to maximize strength and durability of prostheses-bone cement interface; and method of forming same
US9192694B2 (en) Biocompatible and low-abrasion member, and artificial joint using the same and method of producing the same
WO2007116690A1 (en) Biomaterial, artificial joint using the same and method of producing the same
WO2004024200A1 (en) Biocompatible implants
GB2259253A (en) Modular implant system using plastics film to join components
JP2005095584A (en) Implantation material compatible with organism and method for preparation thereof
Lung Surface coatings of titanium and zirconia
CA2247124A1 (en) Improved bone connective prosthesis and method of forming same
EP0679096B1 (en) Load bearing implantable prosthesis
JP3260817B2 (en) Prosthesis and method of manufacturing the same
RU2141292C1 (en) Method of manufacture of ceramic endoprosthesis of knee joint
Raab Endoprosthetic fixation and the implant bone-cement interface

Legal Events

Date Code Title Description
MKEX Expiry